Bilateral Palmar MCP Nodules in a 73-Year-Old Woman
This presentation most likely represents first carpometacarpal (CMC) joint osteoarthritis with possible involvement of the MCP joints, and you should initiate treatment with topical NSAIDs, hand exercises, and strongly consider rigid or neoprene thumb orthoses for the CMC joints.
Initial Diagnostic Approach
The key clinical features to evaluate immediately are:
- Joint distribution pattern: True thumb base (CMC) involvement versus MCP joint involvement - CMC OA is far more common in this age group
- Nodule characteristics: Firm bony enlargement (Heberden's/Bouchard's nodes in OA) versus soft tissue swelling versus discrete mobile nodules
- Inflammatory signs: Warmth, erythema, and morning stiffness >30 minutes suggest inflammatory arthritis rather than OA
- Functional limitations: Pinch grip weakness and difficulty with jar opening are classic for thumb base OA
- Bilateral symmetry: While OA can be bilateral, perfect symmetry raises concern for inflammatory arthritis
Obtain plain radiographs of both hands immediately to differentiate between osteoarthritis (joint space narrowing, osteophytes, subchondral sclerosis) and inflammatory conditions (erosions, periarticular osteopenia) 1, 2.
Critical Differential Diagnosis
While hand OA is most likely given the patient's age and palmar location, you must exclude:
- Rheumatoid arthritis: Can present with MCP involvement and nodules, but typically shows synovitis on examination and positive serology 3, 2
- Acute calcific periarthritis: Presents with acute severe pain and calcific deposits visible on X-ray adjacent to joints 4, 5
- Palmar fibromatosis (Dupuytren's): Presents as palmar nodules but typically involves the palmar fascia, not directly over joints 6
If radiographs are equivocal and inflammatory features persist, ultrasound imaging should be obtained to assess for synovitis and erosions, which can definitively differentiate OA from RA 2.
Evidence-Based Management Algorithm
First-Line Treatment (Initiate Immediately)
Topical NSAIDs: This is the first pharmacological treatment of choice due to superior safety profile in elderly patients 1
Thumb orthoses: For first CMC joint OA, both rigid and neoprene orthoses are strongly recommended with advocacy for long-term use 7, 1. For other hand joints, orthoses are conditionally recommended 7
Hand exercises: Exercises to improve function, muscle strength, and reduce pain should be offered to every patient - this has Grade A evidence 1
Education on ergonomic principles: Training in pacing activities and use of assistive devices should be provided to all patients 1
Second-Line Options
- Oral NSAIDs: Consider for limited duration if topical therapy insufficient, but use cautiously given age-related risks 1
- Intra-articular corticosteroid injections: Generally NOT recommended for hand OA, but may be considered specifically for painful interphalangeal joints 1. For CMC joint OA, concurrent use with topical NSAIDs and conservative measures maximizes benefit 6
Therapies to AVOID
- Do NOT use: Conventional or biological DMARDs - these have no role in OA management 1
- Do NOT use: Systemic corticosteroids, TNF inhibitors, or IL-1 antagonists 7
Common Pitfalls
Pitfall #1: Assuming all bilateral hand nodules in elderly women are OA without imaging. Rheumatoid arthritis can present atypically, and early ultrasound can prevent delayed diagnosis 2.
Pitfall #2: Using intra-articular corticosteroids too liberally in hand OA. The evidence supports their use primarily for interphalangeal joints, not broadly across all hand joints 1. For palmar fibromatosis specifically, corticosteroid injections carry risks of recurrence and adverse effects 6.
Pitfall #3: Failing to emphasize long-term orthosis use. The guidelines specifically advocate for long-term, not just acute, use of thumb orthoses 1.
When to Consider Surgical Referral
Surgery should be considered when conservative treatments fail to adequately relieve pain in the presence of structural abnormalities 1. For thumb base OA specifically, trapeziectomy is the procedure of choice 1.
Follow-Up Strategy
Long-term follow-up should be adapted to individual patient needs 1. Monitor for:
- Response to conservative therapy within 4-6 weeks
- Progressive functional decline despite treatment
- Development of inflammatory features requiring diagnostic reassessment